TXG
10x Genomics, Inc. · Healthcare · Medical - Healthcare Information Services
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham +7.8% · posisi baru bersih 0.0% · formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 153.99K | $11.76M | n/a | n/a |
| Q2 2026 | 113 | +6 | 98.93M | $3.79B | +15 | −8 |
| Q1 2026 | 109 | +3 | 94.02M | $1.99B | +12 | −10 |
| Q4 2025 | 107 | +3 | 97.86M | $1.59B | +4 | n/a |
| Q3 2025 | 19 | -2 | 71.88M | $839.83M | n/a | −3 |
| Q2 2025 | 19 | +1 | 64.66M | $748.72M | +2 | −1 |
| Q1 2025 | 15 | 0 | 30.56M | $266.82M | +1 | −1 |
| Q4 2024 | 15 | +1 | 24.83M | $356.61M | +3 | −2 |
| Q3 2024 | 13 | 0 | 22.71M | $512.82M | +1 | −1 |
| Q2 2024 | 13 | n/a | 21.07M | $409.76M | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 10.75M | +15.4% | $242.74M | 2.2% | ▲ Add | 2 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 2.78M | +731.4% | $62.77M | 0.1% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | T. Rowe Price ✦ | 2.52M | -12.5% | $56.81M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 4 | Geode Capital Management ✦ (pasif) | 1.82M | +2.4% | $41.01M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 5 | Point72 Asset Management ✦ | 1.23M | Baru | $27.78M | 0.1% | New | 1 | SEC ↗ |
| 6 | Millennium Management ✦ | 918.76K | -32.5% | $20.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Capital World Investors ✦ | 793.30K | 0.0% | $17.91M | 0.0% | Held | 2 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 729.03K | +131.3% | $16.37M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 9 | Marshall Wace ✦ | 467.12K | +1219.5% | $10.55M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 10 | Two Sigma Investments ✦ | 337.28K | +146.6% | $7.62M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | PRIMECAP Management ✦ | 295.40K | +58.1% | $6.67M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Norges Bank ✦ (pasif) | 41.07K | -95.9% | $927,383 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Baillie Gifford ✦ | 40.38K | -98.5% | $911,736 | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Point72 Asset Management | $27.78M | 0.1% |
Telah keluar
| Renaissance Technologies | $4.09M | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 328 pemegang, 124.40M saham, $2.59B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer, Director · 1.00K lbr · $78,228
Director · 1.22K lbr · $100,542
Director · 2.27K lbr · $185,391
Director · 1.32K lbr · $107,082
Director · 614 lbr · $48,820
Director · 292 lbr · $22,833
Officer, Director · 2.80K lbr · $230,622
Officer, Director · 9.90K lbr · $810,071
Officer, Director · 9.30K lbr · $752,401
Officer, Director · 2.00K lbr · $159,239
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi